TY - JOUR
T1 - Evidence-based clinical standard for the diagnosis and treatment of candidemia in critically ill patients in the intensive care unit
AU - Cortés, Jorge Alberto
AU - Valderrama-Rios, Martha Carolina
AU - Peçanha-Pietrobom, Paula M.
AU - Júnior, Moacyr Silva
AU - Diaz-Brochero, Cándida
AU - Robles-Torres, Rafael Ricardo
AU - Espinosa-Almanza, Carmelo José
AU - Nocua-Báez, Laura Cristina
AU - Nucci, Marcio
AU - Álvarez-Moreno, Carlos Arturo
AU - Queiroz-Telles, Flavio
AU - Rabagliati, Ricardo
AU - Rojas-Fermín, Rita
AU - Finquelievich, Jorge L.
AU - Riera, Fernando
AU - Cornejo-Juárez, Patricia
AU - Corzo-León, Dora E.
AU - Cuéllar, Luis E.
AU - Zurita, Jeannete
AU - Hernández, Augusto Raúl
AU - Colombo, Arnaldo Lopes
N1 - Publisher Copyright:
© 2024 Sociedade Brasileira de Infectologia
PY - 2025/1/1
Y1 - 2025/1/1
N2 - Candidemia is the predominant form of invasive candidiasis and the most frequently occurring serious fungal infection in critically ill patients in Intensive Care Units (ICU). Studies carried out in Latin America reveal a higher incidence of candidemia and higher mortality rates when compared to North America or Europe. This highlights the need to develop guidelines for correctly diagnosing and treating candidemia in critically ill patients in the ICU. These guidelines are part of the efforts to implement antifungal optimization programs in the region to obtain better clinical outcomes and promote rational antifungal use. This evidence-based clinical standard, established through expert consensus for the Latin American context, contains recommendations and algorithms for diagnosing and treating candidemia in critically ill ICU patients.
AB - Candidemia is the predominant form of invasive candidiasis and the most frequently occurring serious fungal infection in critically ill patients in Intensive Care Units (ICU). Studies carried out in Latin America reveal a higher incidence of candidemia and higher mortality rates when compared to North America or Europe. This highlights the need to develop guidelines for correctly diagnosing and treating candidemia in critically ill patients in the ICU. These guidelines are part of the efforts to implement antifungal optimization programs in the region to obtain better clinical outcomes and promote rational antifungal use. This evidence-based clinical standard, established through expert consensus for the Latin American context, contains recommendations and algorithms for diagnosing and treating candidemia in critically ill ICU patients.
KW - Antifungals
KW - Candidemia
KW - Critical illness
KW - Intensive care units
KW - Latin America
UR - https://doi.org/10.1016/j.bjid.2024.104495
UR - https://linkinghub.elsevier.com/retrieve/pii/S1413867024007773
UR - https://www.mendeley.com/catalogue/88c579ca-f6c3-3fd5-870f-3a122242da1d/
UR - https://www.scopus.com/pages/publications/85212604968
U2 - 10.1016/j.bjid.2024.104495
DO - 10.1016/j.bjid.2024.104495
M3 - Article
SN - 1413-8670
VL - 29
JO - The Brazilian Journal of Infectious Diseases
JF - The Brazilian Journal of Infectious Diseases
IS - 1
M1 - 104495
ER -
ODS 3: Salud y bienestar